Presynaptic neuromodulators like GABA B receptors impose high-pass filters on synaptic transmission, facilitating release when inputs arrive at high frequency. Burke et al. show that, unlike GABA B , dopamine suppresses glutamatergic release in prefrontal cortex independent of frequency, thus regulating synaptic gain.
INTRODUCTION
Neuromodulators regulate synaptic transmission through a wide array of biophysical mechanisms (Chalifoux and Carter, 2011; Seamans and Yang, 2004; Tritsch and Sabatini, 2012) . In presynaptic boutons, neuromodulators can affect the function of voltage-gated calcium channels (CaVs), which in turn alters the probability of vesicle release (P R ) (Branco and Staras, 2009 ). Due to complex interactions between calcium (Ca) influx and vesicle release machinery in the presynaptic active zone, changes in P R typically do not result in a simple change in gain (i.e., a linear scaling of synaptic strength). Canonically, presynaptic modulators change the relative strength of subsequent closely timed synaptic events, a phenomenon termed shortterm plasticity (STP) (Kamiya and Zucker, 1994; Zucker and Regehr, 2002; Hennig, 2013; Jackman and Regehr, 2017) . However, exceptions to this rule have been observed for a variety of neuromodulators and synapses. In these instances, presynaptic modulation suppresses P R without canonical changes in STP (Gao et al., 2001; Seamans et al., 2001; Delaney et al., 2007; Li et al., 2012; Holmes et al., 2017; Tejeda et al., 2017) . Moreover, modulation with and without parallel changes in STP has been observed at a single synapse in response to two different neuromodulators (Hefft et al., 2002; Delaney et al., 2007; Li et al., 2012; Tejeda et al., 2017) . Why this occurs at some synapses and why different neuromodulators evoke different forms of presynaptic suppression are unclear.
In prefrontal cortex (PFC), there is evidence that GABA and dopamine may differentially regulate glutamatergic transmission by activating presynaptic GABA B receptors (GABA B R) and D1/ D5 family dopamine receptors (D1R). At these synapses, GABA B R activation acts as a canonical presynaptic neuromodulator, robustly reducing P R for single presynaptic action potentials (APs) but facilitating later events in a high-frequency burst of APs (Chalifoux and Carter, 2011) . As such, GABA B R activation is thought to impose a high-pass filter on these synapses (Abbott and Regehr, 2004) . How dopamine regulates the same synapses is less clear. Dopamine modestly suppresses glutamatergic excitatory postsynaptic currents when excitatory postsynaptic currents (EPSCs) are evoked by local electrical stimulation (Seamans et al., 2001; Urban et al., 2002) . By contrast, EPSCs between synaptically coupled pairs of glutamatergic neurons are more strongly suppressed, suggesting that dopamine may suppress presynaptic release in an input-specific manner (Gao et al., 2001 (Gao et al., , 2003 Gao and Goldman-Rakic, 2002 ; but see Urban et al., 2002) . Although other lines of evidence suggest a presynaptic site of action, this modulation occurs without a change in STP (Gao et al., 2001; Seamans et al., 2001) . Thus, in contrast to GABA B , dopamine may act non-canonically to regulate presynaptic gain. This may be important for the hypothesized role of D1R in suppressing background noise during working memory tasks in vivo (Vijayraghavan et al., 2007) .
Using a combination of pharmacology, two-photon Ca imaging, and computational modeling, we found that activation of either D1R or GABA B R suppressed P R , but with differential effects on short-term dynamics. We examined D1R modulation at a variety of glutamatergic inputs to PFC and found that D1R suppressed glutamatergic transmission at only a subset of inputs, but did so with no increase in short-term facilitation. At synapses where D1R-mediated suppression was present, GABA B R activation also suppressed vesicular P R but with canonical increases in short-term facilitation. At these synapses, we show that release is likely mediated by a very small number of CaVs and that these CaVs are the targets of both D1R and GABA B R signaling. Interestingly, D1R and GABA B R regulate different biophysical properties of presynaptic CaVs, which alone were sufficient to account for the differences in STP. Thus, the interplay between CaV function and vesicle release machinery, combined with the precise mechanism by which CaVs are regulated, can bias how neuromodulators regulate synaptic transmission.
RESULTS

Dopaminergic Modulation of Glutamatergic Inputs to PFC
To test the sensitivity of specific PFC excitatory inputs to dopaminergic modulation, we made whole-cell recordings from pyramidal cells in layer 5b of PFC and evoked EPSCs either via local electrical stimulation (eEPSC), which recruits an unknown population of inputs, or via optogenetic recruitment of anatomically specified inputs (oEPSC; Figures 1A and 1B ). Stimuli were delivered every 15 s, and resulting EPSCs were monitored in cells voltage-clamped to À80 mV. EPSCs were almost entirely blocked by the AMPA/kainate antagonist NBQX (10 mM; residual current = 1.4% ± 0.8% of baseline, n = 11). Following a stable baseline, D1Rs were activated by application of the D1-selective agonist SKF 83822 (20 mM, with 1 mM of the D2-family antagonist sulpiride present throughout recording). Consistent with previous findings (Seamans et al., 2001) , eEPSCs evoked by local electrical stimulation were only modestly suppressed (Figures 1C and 1E; Norm Amp: 0.88 ± 0.05 of baseline, n = 16, p < 0.05; . This suggests that dopamine has either minimal effects on all glutamatergic inputs to these neurons or perhaps selective effects depending on the input source.
To distinguish between these possibilities, we injected a virus encoding channelrhodopsin2 (ChR2) into six major glutamatergic input sources to mPFC (Figures 1B and S1 ; either AAV5-CaMKIIa-ChR2-EYFP or AAV5-Ef1a-DIO-ChR2-EYFP, see STAR Methods). Injections were made in PFC, both ipsilateral and contralateral to the recording site (iPFC, cPFC); ipsilateral ventral hippocampus (vHPC); contralateral orbitofrontal cortex (cOFC); ipsilateral mediodorsal thalamus (MDT); or ipsilateral amygdala (Amyg). In contrast to local electrical stimulation, optically evoked oEPSCs were modulated by SKF in only 3 of 6 inputs ( Figures 1D, 1F , and 1G)-iPFC, cPFC, and vHPC (iPFC, Norm Amp: 0.62 ± 0.05, n = 13, p < 0.01; cPFC: 0.64 ± 0.04, n = 18, p < 0.01; vHPC: 0.66 ± 0.04, n = 18, p < 0.01; rank-sum test)-and were blocked by the D1 antagonist SCH 23390 (10 mM SCH; Norm Amp: 0.96 ± 0.04, n = 6, p < 0.01 versus SKF alone; rank-sum test; Figure 1H ). Inputs from cOFC, MDT, and Amyg were insensitive to D1 agonist application (cOFC, Norm Amp: 1.03 ± 0.04, n = 8, p = 0.47; MDT: = 1.04 ± 0.04, n = 6, p = 0.37; Amyg: 1.01 ± 0.08, n = 8, p = 0.93; rank-sum test). Taken together, these data suggest that D1Rs suppress a subset of glutamatergic inputs into PFC that is defined, at least in part, by anatomical source. The pattern of modulation observed above can be explained most easily by input-specific, presynaptic actions of D1Rs. To identify the locus of dopaminergic modulation, we first examined the paired-pulse ratio (PPR) and coefficient of variation (CV) of oEPSCs in modulated pathways. At many synapses, reductions in P R are accompanied by an increase in PPR and a decrease in CV
À2
, whereas changes in postsynaptic charge transfer per vesicle lead to reductions in EPSC amplitude with no change in PPR or CV À2 (Clements, 1990; Kamiya and Zucker, 1994; Quastel, 1997; Sigworth, 1980) . We first validated that PPR and CV accurately reflect changes to pre-and postsynaptic aspects of transmission by altering extracellular Ca concentration, which changes P R , or by applying subsaturating concentrations of the AMPA/kainate receptor antagonist NBQX, which attenuates EPSC amplitude without altering P R . These manipulations were calibrated to suppress the amplitude of the first oEPSC to a similar extent as observed after D1R activation. Neither PPR nor CV À2 was affected by NBQX application (40 nM), consistent with its postsynaptic actions (Norm Amp: 0.70 ± 0.04, p < 0.001; Norm PPR = 0.99 ± 0.04, p = 0.86; Norm CV À2 : 0.98 ± 0.05, p = 0.72; n = 8, rank-sum test). In contrast, both PPR and CV À2 co-varied with EPSC amplitude when extracellular Ca concentration was changed (Figures 2A-2C , DCa
2+
; relative to 1.3 mM CaCl 2 . All data normalized to baseline. 2.0 mM, Amp: 1.43 ± 0.07, PPR = 0.82 ± 0.03, CV À2 = 3.00 ± 0.82, n = 9; 0.9 mM, Amp: 0.77 ± 0.06, PPR = 1.11 ± 0.05, CV À2 = 0.43 ± 0.09, n = 10; 0.75 mM, Amp: 0.49 ± 0.06, PPR = 1.30 ± 0.07, CV À2 = 0.53 ± 0.07, n = 9; PPR and postsynaptic manipulations at these synapses.
To examine how PPR is affected by D1Rs, oEPSCs were evoked in each dopamine-sensitive pathway. Comparable levels of paired-pulse facilitation were observed at baseline for iPFC, cPFC, and vHPC inputs (1.31 ± 0.09, 1.31 ± 0.08, and 1.10 ± 0.08, respectively; 50 ms interstimulus interval). Interestingly, PPR was not increased after D1-dependent modulation of iPFC, cPFC, or vHPC inputs (Figures 2A-2C , SKF, for iPFC, cPFC, and vHPC, respectively: Norm PPR = 0.96 ± 0.07, 1.01 ± 0.04, and 0.93 ± 0.07; n = 13, 18, and 18; p = 0.60, 0.83, and 0.20; rank-sum test with Holm-Sidak correction versus PPR = 1.00; chi-square statistic = 1.57, p = 0.67, Kruskal-Wallis), a result consistent with previous studies in PFC (Gao et al., 2001; Seamans et al., 2001) . In contrast, CV À2 was reduced at both prefrontal inputs and trended toward a decrease for ventral hippocampal inputs (iPFC, cPFC, and vHPC, respectively: Norm CV À2 = 0.58 ± 0.07, 0.61 ± 0.09, and 0.82 ± 0.10; p = 0.0001, p = 0.0003, and p = 0.107). Given the disagreement between PPR and CV results, we next sought to isolate pre-and postsynaptic components of synaptic transmission. To examine presynaptic P R , we used optical quantal analysis (OQA), where transmission success and failure can be monitored at single synapses via NMDA receptor-mediated spine Ca influx (Mainen et al., 1999; Oertner et al., 2002; Higley et al., 2009; Little and Carter, 2012) . Pyramidal cells were voltage-clamped to 0 mV to inactivate CaVs, and spines responsive to ChR2 stimuli were identified using Fluo-5F ( Figures  2D-2F) . P R across all tested spines was 0.28 ± 0.03 at baseline (range = 0.10-0.40, n = 11 spines, 30 trials each). After pharmacological activation of D1Rs, P R was significantly reduced (Figures 2E and 2F , success threshold = 2 SD of noise; baseline P R 0.27 ± 0.04, post-SKF P R = 0.13 ± 0.04, n = 7, p < 0.05, signed-rank test). P R was unaltered in time-locked controls (baseline P R = 0.28 ± 0.04, post-vehicle P R = 0.30 ± 0.04, n = 4, p > 0.99, signed-rank test). Data were consistent when using different noise thresholds to define success and failure trials (see STAR Methods; success threshold = 1 SD of noise; SKF baseline P R = 0.33 ± 0.06, post-SKF P R = 0.16 ± 0.04, n = 7, p < 0.05, vehicle baseline P R = 0.28 ± 0.04, post-vehicle P R = 0.35 ± 0.06, n = 4, p = 0.375; success threshold = 3 SD of noise; SKF baseline P R = 0.21 ± 0.05, post-SKF P R = 0.09 ± 0.03, n = 7, p < 0.05, vehicle baseline P R = 0.25 ± 0.02, post-vehicle P R = 0.24 ± 0.03, n = 4, p > 0.99). These data indicate that D1Rs suppress P R at individual PFC synapses.
To isolate potential postsynaptic modulation by D1Rs, we bypassed transmitter release and instead uncaged glutamate on single spines. Uncaging pulses were delivered in a pair with increased intensity on the second pulse to mimic paired-pulse facilitation observed using ChR2 stimulation. No change in uEPSC amplitude or PPR was noted ( Figure S4 ) (Norm uEPSC amplitude = 1.01 ± 0.11 and 0.97 ± 0.06, n = 8 and 11 for SKF and vehicle, respectively; p = 0.62, Mann-Whitney U test, SKF versus vehicle; Unnormalized PPR = 1.45 ± 0.21, 1.41 ± 0.16, 1.41 ± 0.10, and 1.40 ± 0.07, n = 8, 8, 11, and 11 for SKF baseline, post-SKF, vehicle baseline, and post-vehicle, respectively; p = 0.87, Mann-Whitney U test for SKF baseline versus vehicle baseline; p > 0.99, p = 0.86, Wilcoxon signed-rank test for baseline PPR versus post condition for SKF and vehicle, respectively).
D1 receptors are more commonly expressed in thin-tufted layer 5 pyramidal cells in PFC, which have intrinsic cell properties that can be distinguished from neighboring cell classes (Gee et al., 2012; Seong and Carter, 2012; Clarkson et al., 2017) . To determine whether postsynaptic cell type contributes to D1-dependent modulation of oEPSCs, we divided the dataset from Figure 1 not by projection source but by postsynaptic cell class and found that D1R-dependent modulation was present in putative D1-expressing and D1-lacking cell classes ( Figures  S2C and S2D ). Taken together with OQA and uncaging experiments, these data indicate that D1R suppression of long-range EPSCs is due to presynaptic suppression of P R , despite the fact that this modulation does not increase PPR.
How might D1Rs suppress P R without increasing paired-pulse facilitation? D1Rs have been observed to regulate the highvoltage-activated (HVA) CaVs that underlie transmitter release (Surmeier et al., 1995; Zhang et al., 2002; Seamans and Yang, 2004) . To test whether D1Rs regulate presynaptic Ca influx, we imaged Ca in axonal boutons that originated from different long-range inputs using two-photon laser scanning microscopy. We used a viral strategy similar to that used with ChR2, injecting both AAV5-hSyn-DIO-gCaMP6f and AAV5-Ef1a-Cre into the same brain regions as studied above in animals from a Credependent tdTomato reporter line (Ai14; Figure 3A) . In a subset of experiments, we confirmed that gCaMP6f responses were AP-mediated by visually ensuring that responses to a prolonged train of stimuli (503 50 Hz, Figure 3A ) were blocked by 1 mM tetrodotoxin (n = 6 boutons, 3 slices). When assessing D1R modulation, stimuli were limited to 33 50 Hz, as this produced reliable gCaMP signals that were restricted to individual boutons ( Figure S5 , gCaMP full-width half-max 1.70 ± 0.16 mm before stimulus versus 1.68 ± 0.16 mm after stimulus, n = 8, p = 0.88; rank-sum test). Consistent with oEPSC results, D1R activation strongly suppressed AP-evoked Ca influx in axonal boutons from cPFC and vHPC, but not from cOFC, MDT, or Amyg (Figures 3B and 3C ; Norm Peak DF/F = 0.57 ± 0.07, 0.71 ± 0.08, 1.04 ± 0.09, 1.01 ± 0.11, and 0.99 ± 0.07; n = 13, 12, 14, 13, and 10; p < 0.001, p = 0.003, p = 0.64, p = 0.96, and p = 0.72, respectively; rank-sum test with Holm-Sidak correction), and modulation was blocked by SCH 23390 (10 mM; Figure 3D ; for SKF, Vehicle, and SKF+SCH, respectively: Norm Peak DF/F = 0.57 ± 0.07, 1.04 ± 0.05, and 1.03 ± 0.08; n = 13, 7, and 14; chi-square statistic = 14.80, p < 0.001, Kruskal-Wallis; SKF versus Vehicle p < 0.001, SKF versus SKF+SCH p < 0.001; rank-sum test with Holm-Sidak correction). Note that iPFC boutons were not measured with this approach, as boutons could not be resolved within the dense fluorescence of the injection site. Instead, modulation at iPFC boutons was assessed by imaging axon Ca influx with synthetic indicators during wholecell recordings (see Figure 4) . Overall, these data suggest that D1Rs suppress specific PFC glutamatergic inputs by a non-canonical presynaptic mechanism that reduces vesicle P R without increasing paired-pulse facilitation.
Canonical and Non-canonical Presynaptic Modulation at PFC Glutamatergic Inputs
Is dopamine unique in its ability to regulate P R without altering STP, or do other presynaptic neuromodulators have similar effects at these synapses? To address this question, we compared the effects of D1R to GABA B R activation, which is known to suppress release though G bg -dependent modulation of presynaptic CaVs (Chalifoux and Carter, 2011; Otis and Trussell, 1996; Park and Dunlap, 1998; Takahashi et al., 1998) . The GABA B R agonist baclofen (350 nM) suppressed oEPSCs from cPFC inputs to a slightly larger extent than SKF (Figures 4A and 4B ; Norm oEPSC Amp: 0.46 ± 0.05, n = 7, p < 0.001; rank-sum test with HolmSidak correction; compare to Figures 1G and 1H) ; however, CV À2 and PPR decreased and increased, respectively, to an extent that mimicked the reduced extracellular Ca condition (Figure 4B ; Norm CV À2 : 0.39 ± 0.08, p < 0.001; Norm PPR = 1.27 ± 0.10, p = 0.03; rank-sum test with Holm-Sidak correction; see also Figure S3 ). These data indicate that GABA B R-mediated suppression of presynaptic release leads to canonical increases in PPR, suggesting that neuromodulation by GABA B R and D1R may occur through different signaling mechanisms. Previous work has shown that D1Rs, as opposed to G bgdependent GABA B Rs, regulate Ca V 2.1 and Ca V 2.2 CaVs through a protein kinase A-dependent (PKA) pathway (Surmeier et al., 1995; Zhang et al., 2002) . To test this, as well as to measure neuromodulatory effects in iPFC axons, we made whole-cell recordings from layer 5 pyramidal cells and imaged AP-evoked bouton Ca transients with Fluo-5F. Ca transients were suppressed by SKF and baclofen to similar degrees (Figures 4C and 4D ; Norm Peak DF/F = 1.00 ± 0.03, 0.56 ± 0.06, and 0.59 ± 0.05; n = 6 each for vehicle, SKF, and baclofen, respectively), and Ca transients were suppressed by both D1R and GABA B R at individual boutons with serial application of both agonists (Norm Peak DF/F = 0.62 ± 0.03 and 0.44 ± 0.05 for SKF and SKF+baclofen, respectively; n = 7, p < 0.05, signed-rank test). D1-dependent modulation was blocked by the PKA inhibitor H89 (Figures 4C  and 4D ; Norm DF/F = 0.98 ± 0.02, n = 8), whereas GABA B Rdependent modulation was not (Norm DF/F = 0.66 ± 0.05, n = 7; chi-square statistic = 24.1, p < 0.001, Kruskal-Wallis; SKF versus SKF+H89 p < 0.001, SKF versus Vehicle p = 0.002, baclofen versus baclofen+H89 p = 0.366, baclofen versus Vehicle p = 0.002, baclofen+H89 versus Vehicle p = 0.001; rank-sum test with Holm-Sidak correction).
We next tested whether the distinct signaling pathways of D1R and GABA B R result in regulation of different presynaptic CaV subtypes. Application of u-conotoxin-MVIIC (1 mM) blocked oEPSCs by 98.3% ± 0.6% (n = 5, data not shown), indicating that release is mediated by Ca V 2.1 and Ca V 2.2 channels at this synapse. To determine whether D1R and GABA B R selectively regulate one of these channel types, we applied Ca V 2.1-and Ca V 2.2-specific antagonists u-agatoxin-TK (AgaTx, 150 nM) or u-conotoxin-GVIA (CTx, 3 mM; Bender and Trussell, 2009 ), followed by either SKF or baclofen. Though both AgaTx and CTx suppressed Ca transients, neither occluded modulatory effects of D1R or GABA B R. (Figures 4E and 4F ; Norm DF/F = 0.75 ± 0.06 and 0.47 ± 0.06 for AgaTx and AgaTx+SKF, respectively, n = 7, p < 0.05; Norm DF/F = 0.64 ± 0.08 and 0.44 ± 0.08 for AgaTx and AgaTx+Bac, respectively, n = 6, p < 0.05; Norm DF/F = 0.82 ± 0.04 and 0.57 ± 0.06 for CTx and CTx+SKF, respectively, n = 6, p < 0.05; Norm DF/F = 0.80 ± 0.06 and 0.48 ± 0.07 for CTx and CTx+Bac, respectively, n = 7, p < 0.05; signed-rank test for all comparisons). Thus, these data indicate that D1Rs and GABA B Rs both suppress excitatory transmission through reduction of presynaptic AP-evoked Ca influx through Ca V 2.1 and Ca V 2.2 channels, although they act via different signaling cascades.
Given that D1R suppression can occur in conjunction with GABA B R suppression within the same bouton, it is possible that they regulate different biophysical properties of presynaptic CaVs. We reasoned that differential CaV modulation could account for differences in how D1Rs and GABA B Rs regulate vesicle release. Interestingly, a similar dissociation between regulation of P R and short-term dynamics has been observed at hippocampal Schaffer collateral synapses. At this synapse, it has been proposed that vesicle release is mediated by a small number of CaVs (i.e., nanodomain release configuration, Scimemi and Diamond, 2012). In such a configuration, reductions in the amount of Ca fluxed by single CaVs during an AP (i CaV ) can suppress Ca influx, reduce initial P R , and increase PPR through an accumulation of Ca bound to vesicular release machinery (Jackman and Regehr, 2017; Zucker and Regehr, 2002) . By contrast, reductions in the probability a CaV opens in response to an AP (p open ) could have multiple effects. If many CaVs contribute to vesicle release (i.e., microdomain release configuration), then a reduction in p open should simply reduce the total Ca current (I CaV ) and have effects on P R and PPR similar to reductions in Ca current per channel (e.g., single-channel current, i CaV ). However, if very few CaVs contribute to vesicle release, then the likelihood of local Ca influx failures on individual trials (I CaV = 0) becomes non-negligible, and on these trials a reduction in P R may be followed by a lack of facilitation due to the absence of Ca accumulation at Ca sensors that mediate release. Due to differences in dissociation rate, the divalent channel antagonists manganese (Mn) and cadmium (Cd) can differentially suppress i CaV or p open , respectively. Mn, which can bind and dissociate from a CaV many times within the time course of an AP, functionally reduces i CaV , similar to lowering extracellular Ca. In contrast, Cd dissociation rates are an order of magnitude slower than an AP (0.02 ms À1 ; Thé venod and Jones, 1992).
At subsaturating concentrations, individual CaVs will likely be completely blocked or not blocked by Cd during the time course occur through several biophysical mechanisms. For example, GABA B R-induced changes in channel gating, perhaps by depolarizing the voltage dependence of activation or increasing the reluctance of channel opening, could reduce the channel open duration during an AP (Huynh et al., 2015; Mintz and Bean, 1993; Patil et al., 1996) . This would be functionally equivalent to Mn application, as it would produce a partial suppression of Ca influx per channel. By contrast, D1R-dependent modulation that reduces the likelihood that a CaV opens at all in response to an AP would mimic Cd, as it would produce all-or-none suppression of Ca influx per channel.
To test the hypothesis that D1Rs and GABA B Rs differentially regulate the way CaVs respond to AP stimuli, we applied optical fluctuation analysis (OFA) to PFC bouton Ca signals (Carter and Jahr, 2016; Sabatini and Svoboda, 2000) . We made whole-cell recordings and visualized AP-evoked Ca signals in axonal boutons (Figures 6A and 6B) . Boutons were always imaged in serial pairs to ensure that trial-to-trial variability was uncorrelated and thus unlikely to be the result of AP conduction failures (Figures S6A and S6B) . Both the mean amplitude, DhFi, and variance, s ( Figure 6C ). The variance predicted by dark noise and shot noise alone was subtracted from the measured variance to obtain variance related to CaV activity ( Figure 6D ). Analysis of the resulting Ca transients is mathematically similar to EPSC nonstationary fluctuation analysis, but applied to imaging data instead of electrophysiological data (Quastel, 1997; Sigworth, 1980; Sabatini and Svoboda, 2000) . Ca influx in a bouton can be modeled as a binomial process arising from N CaVs, each with single-channel current i and open probability p, and quantitative predictions can be made for how trial-to-trial variability is affected given changes to N, i, or p. Within this framework, the meannormalized variance should not change when reducing the single-channel current i, but it should increase with reductions in N and p. Importantly, the variance should increase more for reductions in p than for similar reductions in N, especially in boutons where CaV open probability per AP is high ( Figure S6C ; Yasuda et al., 2003) . Lastly, because we used propagating APs as our stimulus, i and p reflect the single-channel Ca charge transfer and overall channel open probability per AP, respectively.
In time-locked control conditions, AP-evoked bouton Ca transients were stable for > 100 trials ( Figure 6E ). All subsequent pharmacological experiments were therefore limited to a maximum of 100 trials. Baseline and post-drug measurements of 40-50 trials were separated by $10 min to allow for drug equilibration. Both D1R and GABA B R activation suppressed presynaptic Ca influx ( Figures 6F and 6G ), but decreases in CV
À2
CaV were observed primarily with D1R, not GABA B R, activation (Figures 6H-6K; for D1R and GABA B R, respectively: n = 6 and 6; Norm CV To determine whether D1Rs reduce CaV number or open probability, we compared D1R effects to application of a subsaturating dose of u-conotoxin MVIIC (35 nM). Because the dissociation rate of u-conotoxin MVIIC is substantially slower than the time course of these experiments (McDonough et al., 1996) , it should act as an irreversible CaV antagonist and effectively reduce N. Indeed, CV 
CaV reduced more quickly than hDFi (conotoxin versus SKF p < 0.001; rank-sum test with Holm-Sidak correction), suggesting that D1Rs do not reduce the number of channels at the bouton.
Because D1Rs suppressed CV
CaV more strongly than predicted by reductions in N, we next asked whether D1R suppression was consistent with a reduction in p. In cases where p is modulated, the steepness of the change in CV
CaV depends strongly on the baseline open probability; thus, one can fit observed changes in CV
CaV and hDFi to a nonlinear function parameterized by different estimates of baseline CaV open probability ( Figure S6C ). The observed changes in CV
CaV and hDFi after D1R activation agreed well with a baseline open probability of 0.83 (95% confidence interval = 0.73-0.93), consistent with more direct measures of p at other terminals (Borst and Sakmann, 1998; Li et al., 2007) . Taken together, these data indicate that D1Rs and GABA B Rs suppress presynaptic CaV p open and i CaV , respectively ( Figure 6L ).
To determine whether the different biophysical mechanisms of CaV modulation predicted by OFA are sufficient to explain the differing effects of D1Rs and GABA B Rs on STP, we developed a reduced synaptic model ( Figure 7A ; Table S1 ). We simulated 50 synapses onto a single postsynaptic neuron, where each presynaptic terminal contained a constant number of CaVs. Channel activity was simulated as a simple binomial process to adapt OFA data directly into the model, and vesicle P R was calculated as a Hill function of the Ca concentration per bouton (Stanley, 2016; Zucker and Regehr, 2002) . Note that the resulting total number of vesicles was convolved with an AMPA-like sum of exponential waveforms for visualization, but analysis of EPSC amplitude and PPR was based solely on mean quantal content (see STAR Methods).
We began by assuming that vesicle release was driven by only one CaV per synapse with an open probability of 0.83 per AP (derived from OFA analysis, Figure 6L ; Bucurenciu et al., 2008; Scimemi and Diamond, 2012; Stanley, 2016) . Given this open probability, four different Ca transients were observed with differing probabilities in response to paired-pulse stimulation ( Figure 7A, four rows) . In most cases, both APs resulted in a CaV opening (69% of trials), but in some cases the CaV opened in response to only the first or second AP (14% each) or to neither (3%). This is a direct result of the CaV openings being independent across channels and trials. These probabilities, when translated into release via the Hill function (S = 0.25, cooperativity = 3.72; Scimemi and Diamond, 2012) and aggregated across all 50 simulated synapses, resulted in modest paired-pulse facilitation of quantal content (model PPR = 1.14, compared to measured oEPSC PPR of 1.31 ± 0.09, 1.31 ± 0.08, and 1.10 ± 0.08 for iPFC, cPFC, and vHPC, respectively).
Given these baseline conditions, we next altered either the CaV single-channel current (i) or open probability (p) per AP to an extent that matched the D1R and GABA B R OFA data (0.6 of baseline for either model parameter, Figures 7B and 7C ; compared to peak DG/R amplitude reduction to 0.56 ± 0.06 and 0.59 ± 0.05 of baseline for D1R and GABA B R, Figure 6L ). Modulation of i strongly reduced P R due to the Hill function nonlinearity described above. As such, differences in residual Ca levels after the first AP nonlinearly enhanced P R on the second AP, and PPR was increased. By contrast, when only one CaV contributed to release per synapse, modulation of p did not change Ca transient amplitude ratios or residual Ca; instead, modulation of p decreased the likelihood of two APs both eliciting successful Ca influx and increased the likelihood that Ca influx would occur on only the first AP, only the second AP, or not at all. Thus, when aggregated across all synapses and trials, the net EPSC amplitude was reduced without increasing PPR. In fact, more dramatic reductions in p led to a small decrease in PPR. This is because our simulations were tuned to evoke modest PPF at baseline, matching empirical observations (Figure 2) , and as p decreased, the likelihood of successful Ca influx for both APs (and thus, facilitation) approached zero. As a result, the net EPSC will be weighted more heavily toward Ca influx failures, and PPR will trend toward 1, which would appear as a decrease when normalized to facilitation at baseline ( Figures  5C-5E ). This result did not depend on the exact values chosen for the Ca concentration decay time constant or interval between APs and was also observed when synapses had a distribution of channel numbers and Ca decay time constants ( Figures  S7A-S7C) .
Synaptic facilitation can occur through multiple mechanisms, including slow clearance of Ca from the presynaptic terminal (i.e., the residual Ca hypothesis, Jackman and Regehr, 2017), saturation of endogenous Ca buffers (i.e., the buffer hypothesis, Blatow et al., 2003; Rozov et al., 2001) , or interactions with a high-affinity Ca sensor that has Ca dissociation kinetics that are slower than the paired-pulse interval (e.g., synaptotagmin7, bound Ca hypothesis, Jackman et al., 2016) . While the simulations described above use residual Ca as a mechanism for facilitation in a highly reduced manner, similar results were obtained with a model that incorporates three additional, more realistic features ( Figures S7D-S7I) . First, rather than simulating the bouton as a point, the linearized buffer approximation (''LBA,'' Naraghi and Neher, 1998) was used to approximate Ca concentration as a function of distance from the CaV. Then, Cadependent short-term facilitation was generated by scaling P R by a second, higher-affinity Hill function with Ca affinity and cooperativity derived from synaptotagmin7 (see STAR Methods  and Table S1 ). Last, a simple model of vesicle depletion and replenishment was added, which is critical to generate Cadependent short-term facilitation in this form of model (Scimemi and Diamond, 2012) . Paralleling results from our simpler model, the same basic pattern of canonical and noncanonical modulation with changes in i and p was observed when only a few CaVs were responsible for release, especially for CaV-vesicle distances that reflect tight diffusional coupling (< 25 nm, Bucurenciu et al., 2010; Nakamura et al., 2018; Scimemi and Diamond, 2012; Figure S7D-S7H) . This is likely because noncanonical STP due to suppression of p occurs upstream of release machinery and Ca diffusion dynamics, and because the ''paired-pulse facilitation'' of intracellular Ca also trends toward 1 in these conditions. To further illustrate this point, we built a linear phenomenological model of short-term facilitation (Figures S7J-S7L ; Betz, 1970; Varela et al., 1997; Markram et al., 1998) . This model makes no assumptions about the cellular mechanisms that support facilitation; its only requirement is that facilitation is Ca dependent. Even here, we observed the same differences in PPR modulation by changes in i and p. Thus, these models can account for different mechanisms by which facilitation could occur, including buffer saturation or a high-affinity Ca sensor with slow kinetics, provided that facilitation depends on residual Ca in some way. This PPR dependence on i but not p was consistent across a range of parameter reductions ( Figures 7D and 7E) . As expected, reductions in quantal size q vesicle did not alter PPR, and the insensitivity of PPR to reductions in p was diminished as the number of CaVs driving release per synapse increased ( Figures 7F-7H ). PPR invariance was observed only when few channels (1-3), either uniformly or randomly distributed across boutons, contributed to release ( Figures 7D, 7F-7H , S7C, S7F, S7I, and S7L). Importantly, this model also reproduced our finding that CV analysis indicated a presynaptic site of action for all tested presynaptic configurations but not the postsynaptic modulation of q vesicle ( Figure 7I ). Taken together with OFA results, these data indicate that the different effects of D1Rs and GABA B Rs on short-term facilitation can, in principle, be explained by differential modulation of presynaptic CaVs.
Non-canonical Presynaptic Modulation Strongly Suppresses Ongoing Activity
Given these differences in STP, we next sought to determine how ongoing activity was shaped by these two neuromodulators. We stimulated cPFC inputs expressing ChR2 with trains of 10 light pulses at either a regular frequency of 20, 10, or 5 Hz or at a combination of these three frequencies ( Figures  8A-8F ). We found that stimulation of D1Rs consistently suppressed the entire sequence of all ten oEPSCs ( Figure 8A ) and often suppressed oEPSCs that occurred at the end of the train to the greatest extent ( Figures 8B and 8E) . But due to increased PPR, GABA B R suppression of oEPSCs was clearer at the beginning of trains, with little difference in oEPSC amplitude toward the end (Figures 8C-8E ). This pattern was observed across multiple frequencies as well as with stimulation of variable intervals ( Figure S8A ). We quantified the ''charge ratio,'' DR Q , which measures the suppression of trains of oEPSCs normalized to the suppression of the first oEPSC. When DR Q < 1 or DR Q > 1, the entire sequence of stimuli was suppressed more or less than the initial stimulus, respectively. D1Rs and GABA B Rs showed significantly different values of DR Q across multiple frequencies ( Figure 8F , DR Q : SKF, n = 7, 20 Hz = 0.73 ± 0.08, 10 Hz = 0.71 ± 0.05, 5 Hz = 0.70 ± 0.08, Mixed Intervals = 0.71 ± 0.05; DR Q : baclofen, n = 7, 20 Hz = 1.38 ± 0.06, 10 Hz = 1.33 ± 0.12, 5 Hz = 1.14 ± 0.08, Mixed Intervals = 1.34 ± 0.08; chi-square statistic = 40.48, p < 0.001, Kruskal-Wallis; SKF versus baclofen, 20 Hz p < 0.001, 10 Hz p < 0.001, 5 Hz p = 0.002, Mixed Intervals p < 0.001; rank-sum test with Holm-Sidak correction). These data suggest that GABA B Rs act as a high-pass filter on synaptic transmission, whereas D1Rs act to suppress synaptic transmission independent of event timing.
We next sought to test whether these differences in STP translate to differences in AP generation in more realistic, in vivo-like conditions. We performed current-clamp experiments where we injected a noisy current waveform stimulus that was comprised of randomly generated simulated EPSCs and IPSCs in order to depolarize the postsynaptic cell and generate APs. We also generated a train of LED pulses with shuffled intervals, ranging from 1 to 20 Hz in frequency, to activate long-range ChR2-expressing cPFC inputs ( Figure 8G ). Stimulation of these inputs by the LED generated short-latency APs in the recorded postsynaptic neuron (Figures 8H-8I ). Importantly, due in part to the injected noisy current waveform, LED stimulation did not generate APs on every trial. This allowed us to apply D1R or GABA B R agonists and test whether these neuromodulators suppress ChR2-mediated spiking in different ways depending on ChR2 stimulation frequency. At the slowest frequency of 1 Hz, LED-evoked spiking was suppressed significantly by both D1R and GABA B R agonists (norm spike frequency within 12 ms of LED = 0.43 ± 0.07 and 0.38 ± 0.05 for SKF and baclofen, respectively). However, as the input LED frequency increased, GABA B R-mediated suppression weakened significantly, whereas D1R-mediated suppression remained similar across all frequencies ( Figures 8I, 8J , and S8B; Norm frequency after SKF = 0.43 ± 0.07, 0.55 ± 0.07, 0.49 ± 0.09, and 0.50 ± 0.20 for 1, 5, 10, and 20 Hz, respectively, n = 6, chi-square statistic = 1.25, p = 0.74, Kruskal-Wallis; Norm frequency after baclofen = 0.38 ± 0.05, 0.82 ± 0.06, 0.74 ± 0.06, and 0.82 ± 0.04 for 1, 5, 10, and 20 Hz, respectively, n = 8, chi-square statistic = 16.08, p < 0.05, Kruskal-Wallis; p < 0.05 for baclofen 1 Hz versus all other frequencies; rank-sum test with Holm-Sidak correction). Thus, these data indicate that GABA and dopamine have differential effects on synaptic integration, with GABA facilitating the transmission of inputs that occur in high-frequency bursts and dopamine suppressing transmission in a frequency-independent manner.
DISCUSSION
We demonstrate here that activation of the D1 dopamine receptor suppresses a subset of excitatory long-range and local inputs in PFC. By reducing presynaptic CaV open probability, D1R can suppress vesicle P R without a parallel increase in short-term facilitation. This non-canonical presynaptic neuromodulation suppresses AP generation across multiple stimulation frequencies and is well explained by a simple synapse model where vesicle release is mediated by a small number of CaVs.
These results provide mechanistic insight into how modulation of specific biophysical properties of presynaptic CaVs can result in surprisingly large differences in synaptic transmission and STP. These data address a long-standing puzzle related to prefrontal dopaminergic modulation by explaining how a neuromodulator can have little effect on paired-pulse facilitation despite a presynaptic site of action (Gao et al., 2001; Seamans et al., 2001; Gao and Goldman-Rakic, 2002; Seamans and Yang, 2004) . In addition to prefrontal cortical synapses, the mechanisms identified here may account for similar observations made in a diverse set of synapses and neuromodulatory systems (Behr et al., 2000; Delaney et al., 2007; Holmes et al., 2017; Li et al., 2012; Tejeda et al., 2017) . In future work, it will be critical to understand the role that distinct canonical and non-canonical presynaptic modulatory pathways play in information transfer in neuronal networks.
CaV-Vesicle Coupling and Presynaptic Neuromodulation
The facilitation-independent form of presynaptic modulation described here requires that release is mediated by nanodomain coupling between only a few CaVs per vesicle (Figure 7 ; Scimemi and Diamond, 2012) . This configuration is similar to other synapses, including the mature calyx of Held (Fedchyshyn and Wang, 2005) , cochlear and retinal ribbon synapses (Goutman and Glowatzki, 2007; Jarsky et al., 2016) , hippocampal basket cell boutons (Bucurenciu et al., 2010) , and Schaffer collaterals (Scimemi and Diamond, 2012) . In the nanodomain configuration, the overall Ca concentration that triggers release is strongly influenced by the stochastic opening of individual CaVs, and as such, slow CaV antagonists like Cd suppress release without increasing PPR ( Figure 5 ; Hefft et al., 2002; Hjelmstad, 2004; Scimemi and Diamond, 2012) . By contrast, when release is mediated by Ca microdomains, the overall Ca concentration is less influenced by single-channel stochasticity. At microdomain synapses, including the immature calyx of Held (Fedchyshyn and Wang, 2005) , Cd suppresses release while also increasing PPR (Otis and Trussell, 1996) . We explored this difference between nanodomains and microdomains in our reduced model by examining how changing the number of functional CaVs per synapse affects the response of the model synapse to modulation of i CaV or p open (Figure 7) . Indeed, we observed that reductions in CaV p open preserved paired-pulse facilitation in the nanodomain-like configuration, but increased facilitation in the microdomain-like configuration. These differences have been proposed previously (Eggermann et al., 2011) and may account for why D1Rs suppress release with and without changes in PPR at different synapses (e.g., Wang et al., 2012) . Presynaptic gain modulation has been observed with several synapses and neuromodulators. At hippocampal Schaffer collaterals, where release is driven by few CaVs, reducing CaV p open with Cd does not increase PPR (Scimemi and Diamond, 2012) . At the perforant pathway synapse in subiculum, D1R also suppresses presynaptic gain (Behr et al., 2000) . In the nucleus accumbens, excitatory inputs from amygdala, but not ventral hippocampus, display PPR-independent P R suppression (Tejeda et al., 2017) . At this synapse, both kappa-opioid receptors (KORs) and GABA B R suppress P R ; however, KORs do not change PPR, whereas GABA B Rs increase PPR. Presynaptic gain modulation at other synapses, including KOR suppression in the bed nucleus of the stria terminalis and noradrenergic suppression in central amygdala, has been attributed to a reduction in the number of presynaptic release sites (Delaney et al., 2007; Li et al., 2012 ; but see Saviane and Silver, 2006) . Taken together, the prevalence of neuromodulators that suppress release without increasing PPR throughout the brain suggests that presynaptic gain modulation may be a more common phenomenon than previously appreciated.
Possible Mechanisms of CaV Modulation
Both D1Rs and GABA B Rs are known to modulate HVA CaVs (Surmeier et al., 1995; Zhang et al., 2002; Kisilevsky et al., 2008; Chalifoux and Carter, 2011) . Our imaging and pharmacological experiments suggest that GABA B Rs and D1Rs modulate AP-evoked Ca influx in a graded or all-or-none manner, respectively, at individual presynaptic CaVs. Multiple biophysical mechanisms could underlie these observations. GABA B Rs could modify AP waveform by recruiting inward rectifying potassium channels or modulating other potassium channels, though the former has not been observed in PFC pyramidal cell axons (Xia et al., 2014) . Alternatively, partial reductions in the current fluxed by single CaVs per AP could result from a GABA B R-induced reduction in channel conductance, delayed time to first opening, or depolarized shift in voltage-dependent activation. The latter two possibilities seem most likely, as GABA B Rs have been shown to interact directly with CaVs via G bg subunits to either induce a rightward shift in activation or delay the time of first opening via the induction of a ''reluctant state'' (Huynh et al., 2015; Mintz and Bean, 1993; Patil et al., 1996) , whereas GABA B R-mediated changes in channel conductance have not been reported. The PKA independence of CaV modulation by GABA B Rs observed in the current study suggests that a similar G bg mechanism may be present at prefrontal synapses.
D1R modulation was PKA dependent, similar to previous reports in basal ganglia (Surmeier et al., 1995; Zhang et al., 2002) , and produced all-or-none reductions in AP-evoked CaV opening. This could be instantiated biophysically through alterations in gating modes, perhaps through modulation of beta subunits that increase channel opening latency to an extent that exceeds the duration of the AP (Luvisetto et al., 2004) . Alternatively, hyperpolarized shifts in steady-state inactivation could reduce the number of channels available for activation by an AP. Such modulatory effects have been observed with D3 dopamine receptor-dependent regulation of Ca V 3.2 channels at the axon initial segment (Bender et al., 2010; Yang et al., 2016; Clarkson et al., 2017) . Ca V 2 channels could be modified by similar mechanisms, especially during AP trains (Patil et al., 1998) . Overall, these data suggest that further investigation into the signaling pathways and biophysics of CaV channel modulation by dopamine and other metabotropic receptors will yield greater insight into the diversity of synaptic neuromodulation in the axon.
Functional Implications
Regulating synaptic gain is an important mechanism for shaping information transfer throughout the brain. Traditionally, gain modulation has been thought to occur at the postsynaptic site, either through changes in neurotransmitter receptor number, modulation of cable properties, or recruitment of inhibition (Silver, 2010) . Because these mechanisms target the postsynaptic membrane, they often modulate overall neuronal excitability and are not input specific. By contrast, neuromodulation of P R is intrinsically input specific. Canonically, neuromodulation of P R has nonlinear and frequency-dependent effects on synaptic transmission (e.g., parallel changes in facilitation and/or depression, see GABA B R in Figure 8) . Thus, the ability of D1R to noncanonically suppress P R at the presynaptic axon without increasing paired-pulse facilitation represents a novel mechanism for input-specific synaptic gain modulation.
Why do D1Rs suppress synaptic gain, rather than impose a canonical high-pass filter? Cortical neuronal activity is often characterized by sparse and irregular firing patterns (Barth and Poulet, 2012; Boudewijns et al., 2013) , with high-frequency bursts encoding behaviorally relevant events (Burgos-Robles et al., 2007; Holmes et al., 2012; Laviolette et al., 2005) . Canonical presynaptic neuromodulators like GABA B Rs that suppress only low-frequency input are thought to be capable of enhancing the signal-to-noise ratio of these bursts. Conversely, D1R modulation may serve to suppress specific inputs into PFC, independent of input frequency. One major function of dopamine during working memory is to improve the saliency of taskrelated signals, largely by suppressing activity unrelated to the task at hand in a PKA-dependent manner (Arnsten et al., 1994; Brozoski et al., 1979; Vijayraghavan et al., 2007) . Dopamine, by suppressing glutamatergic activity without altering short-term dynamics, may contribute to this noise suppression. Moreover, we now know that interactions between MDT and PFC are critical for working memory and attentional control (Bolkan et al., 2017; Schmitt et al., 2017) . One interesting possibility, highlighted by the input-specific modulation shown here, is that D1Rs functionally enhance the signal-to-noise ratio on MDT inputs by suppressing many other inputs. Thus, the gain modulation employed by dopamine may confer advantages to information processing in PFC, especially during working memory.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All procedures were performed in accordance with UCSF IACUC guidelines. C57B6 wild type mice or Ai14 reporter mice (Jackson Laboratory, stock no. 007914) aged postnatal day (P) 50-80 were used for all experiments, with the exception of optical fluctuation experiments (Figure 7) where animals from the age range P35-45 were used. No significant differences based on sex were observed, and data were pooled between sexes.
METHOD DETAILS Viral Injections
Subjects were injected with virus at P26-35. Prior to viral injection, mice were anesthetized by isofluorane and head-fixed in a stereotaxic frame. For channelrhodopsin stimulation experiments, subjects were then unilaterally injected with 300-500 nL of AAV5-CamKIIa-hChR2(H134R)-eYFP (''CaMKII-ChR2'') virus into prefrontal cortex (cPFC, from bregma: A/P +1. For sparse transfection of local recurrent PFC connections (iPFC), the same coordinates as cPFC were used but instead a virus cocktail was injected including AAV5-EF1a-Cre-IRES-mCherry and AAV5-EF1a-DIO-hChR2(H134R)-eYFP (''Cre-mCherry'' and ''DIO-ChR2'', ratios between 1:10 and 1:20). For gCaMP experiments, the same injection coordinates and volumes were used in Ai14 heterozygous animals with a viral cocktail that contained a 1:1 ratio of AAV5-hSyn-Flex-gCaMP6f-WPRE-SV40 and Cre-mCherry. Experiments were then performed approximately 4-8 weeks after injection (4-5 weeks cPFC/iPFC/cOFC, 5-6 MD-Thal/Amyg, 6-8 vHPC) to allow sufficient expression and trafficking. Acute slices were prepared from the majority of subjects. Additional subjects were perfused transcardially with 4% paraformaldehyde in phosphate buffered saline (PBS) and coronal sections were prepared (40 mm thickness). Tissue was rinsed with PBS 3 times over the course of 10 min, and then blocked in a solution of PBS with 10% normal goat serum (NGS, Jackson ImmunoResearch) and 0.2% Triton-X in PBS (PBS-T) for 1 hr. Tissue was then incubated in a solution of 2% NGS and 0.1% PBS-T containing an antibody conjugated to a 488 fluorophore (Invitrogen) to amplify the signal from stereotaxic injections of YFP-expressing viruses. This solution was incubated overnight at 4 C, rinsed with PBS 5 times over the course of 20 min, and mounted on slides with ProLong Gold Antifade with DAPI (Life Technologies). Images were obtained using a high speed wide-field microscope (Nikon Ti, with Andor Zyla 5.5 sCMOS) with a 10x/0.45 or 20x/0.75 Plan Apo objectives. Data were post-processed to stitch images and for brightness and contrast in FIJI.
Slice Preparation and Whole-Cell Recordings
Acute coronal slices of prefrontal cortex (225-300 mm) as well as the injection site if a virus was used (for post-hoc confirmation) were cut in high-sucrose solution, bubbled with 5% CO 2 /95% O 2 and maintained at 4 C. Cutting solution contained (in mM): 87 mM NaCl, 25 mM NaHCO 3 , 25 mM glucose, 75 mM sucrose, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 0.5 mM CaCl 2 and 7 mM MgCl 2 . Following cutting, slices were incubated in artificial cerebrospinal fluid (aCSF, see below) for 30 min at 33 C, then at room temperature until recording. Pyramidal cells were visualized with Dodt contrast and two-photon microscopy. Single neurons were identified for electrical recording based on laminar position and teardrop somatic morphology. External aCSF recording solution contained (in mM): 125 NaCl, 2.5 KCl, 1 MgCl 2 , 25 NaHCO 3 , 1.25 NaH 2 PO 4 , 25 glucose; bubbled with 5% CO 2 /95% O 2 ; 30-33 C. The day of the experiment, 1.3 mM CaCl 2 and 1 mM sulpiride (D2/3/4 antagonist, Tocris) were added to the aCSF from stock solutions. Recordings were performed in voltage-clamp with glass patch electrodes (2-4 MU tip resistance) and internal solution containing (in mM): 113 K-Gluconate, 9 HEPES, 4.5 MgCl 2 , 0.1 EGTA, 14 Tris 2 -phosphocreatine, 4 Na2-ATP, 0.3 tris-GTP; $290 mOsm, pH: 7.2-7.25. Cells were compensated for whole-cell capacitance and series resistance (50%) and voltage-clamped at À80 mV (corrected for 12 mV junction potential) unless otherwise stated. For cesium-based imaging experiments ( Figures 2D-2F , OQA), internal solution contained (in mM): 110 CsMeSO 3 , 40 HEPES, 1 KCl, 4 NaCl, 4 Mg-ATP, 10 Na-phosphocreatine, 0.4 Na 2 -GTP, 0.25 Fluo-5F, 0.02 Alexa 594; $290 mOsm, pH: 7.2-7.25, data corrected for 11 mV junction. Electrophysiological data were acquired at 20 kHz and filtered at 3 kHz using a Multiclamp 700A or 700B amplifier (Molecular Devices) and a custom data acquisition program in Igor Pro (Wavemetrics).
Synaptic Stimulation Experiments and Pharmacology
For channelrhodopsin stimulation experiments (Figures 1, 2, 4 , 5, 8, S1, S2), pairs of blue light stimulation (472 nm LED through 40x objective, 2 x 1 ms at 20 Hz, or more complex patterns in Figure 8 ) or stimulation via theta stimulating electrode (2 x 200 ms at 20 Hz, Figures 1C and 1E ) occurred at regular 15 s intervals to avoid induction of plasticity. Theta simulating electrodes were placed $100-150 mm lateral to the recording electrode, within layer 5. Light power or electrode amperage were adjusted for each cell to minimize polysynaptic responses, but generally ranged from 0.5 to 2 mW/mm 2 and 0.01-0.2 mA, respectively. Pyramidal cell subtype was identified based on intrinsic excitability during the first 2 min of recording, as described previously ( Figure S2 , Clarkson et al. 2017) . The following criteria were used to exclude cells from data analysis: (1) total temperature range of >1.0 C within one experiment, (2) series resistance (Rs) of >20 MU or change in Rs of >20%, (3) holding current (I hold ) < À100 pA, or change in I hold > ± 50 pA, (4) change in input resistance (R in ) > 25%, (5) violation of any of these criteria sooner than 5 min after the last measurement timepoint.
Baseline data began 10 min post-break in (about 7-8 min after start of light stimulation) and lasted for at least 10 min. If a stable baseline EPSC trace was observed, SKF-83822 (D1/D5 agonist, Tocris) was dissolved to 10 mM in ethanol vehicle then immediately (<1 min) diluted in aCSF (20 mM) and applied to the slice for 10 min, followed by washout into baseline aCSF. Similar approaches were applied for other pharmacological manipulations, including (R)-Baclofen, NBQX, manganese and cadmium, as well as changing extracellular calcium concentration, (distilled H 2 O was used as vehicle for all drugs besides SKF, see Results for concentrations). For PKA blockade experiments (Figure 4) , the PKA antagonist H89 was present in all recording solutions (10 mM) as well as the incubation chamber for at least 30 min prior to recording. The D1R antagonist SCH was similarly present in all recording solutions for D1R blockade experiments (Figures 1 and 3) . For agatoxin TK, u-conotoxin GVIA and u-conotoxin MVIIC (Figures 4 and 6) , aCSF was recirculated with the addition of 0.1 mg/mL bovine serum albumin. All drugs were obtained from Tocris Bioscience, with the exception of calcium channel peptide antagonists (agatoxin and u-conotoxin GVIA and MVIIC) and bovine serum albumin, which were obtained from Peptides International and Sigma-Aldrich, respectively.
Imaging Experiments
For gCaMP experiments, external aCSF also included 50 mM picrotoxin, 10 mM NBQX or DNQX and 10 mM (R)-CPP to block GABA-A, AMPA, and NMDA receptors, respectively. AP-evoked bouton gCaMP transients were evoked by a theta-barrel electrode positioned >100 mm from imaged boutons. Boutons were identified via two-photon microscopy (910 nm) based on the string-of-pearls morphology in the red channel (tdTomato/mCherry expression) and sensitivity of green channel fluorescence to extracellular stimulation (gCaMP expression). A train of three extracellular stimulations (200 ms at 20 ms interval) was delivered to evoke boutonrestricted, tetrodotoxin-sensitive gCaMP signals. Approximately 20-30 trials were obtained, followed by application of drug (as with ChR2 stimulation experiments) and another 20-30 trials. Data are displayed as DF/F, or as peak DF/F normalized to the baseline mean peak DF/F.
For imaging of local PFC boutons, K-Gluconate internal solution was used as in ChR2 stimulation experiments, except EGTA was replaced with 250 mM Fluo-5F and 20 mM Alexa 594. Axons were traced to find an offshoot that contained the string-of-pearls morphology, and calcium influx was elicited via precisely timed single action potentials generated by short current injections at the soma (2-2.5 nA x 2 ms). The same inclusion criteria applied to ChR2 stimulation experiments were applied here, except the holding-current criterion was modified for current-clamp (exclude if membrane voltage (V m ) > À63 mV or changed by > ±5 mV). Data were always obtained simultaneously from two neighboring boutons to determine whether variability correlated across boutons (see ''Optical Fluctuation Analysis'').
For imaging of postsynaptic spines during uncaging experiments ( Figure S4 ) slices were perfused with 3 mM MNI-caged-L-glutamate, and 20 mM Alexa 488 was added to the internal solution. Neurons were imaged at 810 nm and MNI-glutamate was uncaged at 720 nm (1 ms pulses, 5-8 mW at focal point). Spines on the basal dendrites within 15 mm of the slice surface were chosen for uncaging. EPSC amplitudes were calculated from the average of 5-10 trials before and 10 min after SKF or vehicle application. Paired pulses with modest facilitation were obtained by increasing the laser intensity by 40% on the second pulse.
For imaging of postsynaptic spines during Optical Quantal Analysis experiments ( Figures 2D-2F ), cells were filled with Cs internal solution containing 250 mM Fluo-5F and 20 mM Alexa 594. Experiments were done in the presence of 10 mM NBQX and 10 mM D-Serine. Neurons were voltage-clamped at 0 mV and trains of 5x LED pulses were delivered to the slice in frame-scan mode at 0.06 Hz to locate spines with detectable Ca transients. Due to changes in microscope configuration to allow for simultaneous LED stimulation and imaging, fluorescence was collected on substage detectors only. To avoid damage to our GaAsP PMTs from the LED, a fast physical shutter was inserted in the detection path between the substage periscope and PMT beamsplitter cube housing (Sutter IQ35). Success trials (Figures 2E and 2F) were defined when peak DF/F exceeded 1, 2, or 3 standard deviations of baseline DF/F noise within 10 ms of shutter reopening.
Optical Fluctuation Analysis
Optical fluctuation analysis models calcium influx as a binomial process arising from N CaVs, each with single-channel current i and open probability p. This process is similar to nonstationary fluctuation analysis of electrophysiological recordings, but modified to account for added sources of variability in imaging data that do not reflect variance in channel opening, including dark noise and shot noise. Because variances add linearly, the variance predicted by dark noise and shot noise alone can be subtracted from the measured variance to obtain variance related to CaV activity ( Figure 6D ):
where dark noise, s (Equation 1B) and shot noise, s 2 s , is the product of the mean change in peak fluorescence, hDFi, and the intensity per photon (in arbitrary units), q:
The dark-noise parameter, s 2 d;p , was measured in every experiment during the initial 50 ms of each trial (see Figure 6B ) by measuring the variance at each pixel over multiple trials and averaging this variance across pixels. The shot-noise parameter q was estimated by imaging a pipette filled with fluorescein with varying laser intensities and fitting the observed variance to the line:
Once q and s 2 d;p are measured, the inverse-square of the CaV-related coefficient of variation can then be estimated as:
One can make quantitative predictions as to how this variance should vary with hFi under different conditions. Specifically, CV À2 CaV should either reduce linearly, not change, or reduce quickly (nonlinearly, as a ''linear rational function'') with reductions in N, i, or p, respectively:
where R = hF post i=hF baseline i and k = p baseline . To ensure that variance was related to fluctuations in CaV activity, care was taken to minimize other sources of variance, including optical drift. Data were excluded if: (1) the timing of the action potential peak changed by > 0.1 ms), (2) trial-by-trial variability in peak DG/R after the AP was correlated when monitored between two simultaneously imaged boutons in series, or (3) failures were observed in both boutons within the same trial, as these effects could result from AP conduction failures rather than independent CaV opening failures. Furthermore, time-locked vehicle controls showed no rundown of more than 5% up to 100 trials, after which spontaneous rundown of peak DG/R was occasionally observed; therefore, all OFA experiments were limited to a maximum of 100 trials, and variance was estimated with trial-to-trial correction for drift:
where n is the number of trials. This is equivalent to the standard measurement of variance as the sum of squared difference from the mean for an experiment without systematic drift, but has the advantage of minimizing unwanted increases in variance due to runup or rundown.
Computational Modeling
All modeling was performed in Python 3.5 (Numpy version 1.11). Images in Figure 7 were generated using Matplotlib version 2.0. See Table S1 for a comprehensive list of model parameters in all models. Models were subjected to continuous integration testing using pytest via Travis CI (https://travis-ci.org/kenburke/synapseModel) to ensure successful execution across a wide range of combinations of parameter values, including rejection of invalid parameters (e.g., negative channel open probabilities or trial numbers).
We first designed a reduced computational model of synaptic transmission in order to directly incorporate the binomial parameters obtained from optical fluctuation analysis. We simulated 50 presynaptic axons, where calcium influx in response to each simulated action potential was modeled as the result of a binomial process resulting from N CaVs, each with independent probability p of increasing the calcium concentration instantaneously by amount i (in arbitrary units). Calcium concentration decayed with a single-exponential time course (time constant = 50 ms, fit alongside Hill function to produce modest paired-pulse facilitation, Brenowitz and Regehr, 2007) . We simulated the stochastic opening of single CaVs using a Monte Carlo method by generating an array of random uniformly distributed numbers in the range ½0; 1Þ and testing whether the generated numbers were less than the open probability p on any given trial. Total calcium concentration was then calculated as the sum of all successful CaV openings (i current each) and residual calcium present from previous APs.
Vesicle release probability (P R ) was then calculated per synapse as a Hill function of the calcium concentration (when zero CaVs opened in response to a stimulus, P R was set to zero to prevent release purely due to residual calcium). The maximum P R per vesicle was a parameter that we hand-tuned in order to obtain realistic values of P R (see Table S1 , ''vesicle_prox''). Individual release events were then modeled using a Monte Carlo method akin to CaV channel openings. Total quantal content was calculated as the total number of successful vesicle release events across synapses for a single trial. Quantal content was convolved with an AMPA-like waveform (kinetics adapted from Jonas et al., 1993) for visualization purposes only, as we wanted to avoid the contribution of postsynaptic filtering in our estimation of neurotransmitter release statistics. This process was repeated 10,000 times for each parameter set tested. Modulation of individual model parameters (e.g., i CaV or p open ) repeated this array of 10,000 simulations for a range of parameter values, scaling the parameter from 20% to 100% of its baseline value in 5% increments. In order to make fair comparisons between presynaptic configurations with differing numbers of CaVs driving release, we held constant the expected average calcium influx (the product N CaV $ i CaV $ p open ). This was achieved by multiplying the number of CaVs and dividing the single-channel current by the same parameter, ''num_cav_ratio'' (see Table S1 ). PPR and CV À2 were calculated using the quantal content rather than the peak AMPA current for computational efficiency because they were mathematically equivalent. Simulation runs were then saved in a.pkl format for subsequent reference and replication.
In a second simulation, we modeled the diffusion of calcium from CaVs to vesicles explicitly using the ''linearized buffer approximation'' (Naraghi and Neher, 1997; Neher, 1998) :
where i CaV = 0:13 pA (Li et al., 2007; Scimemi and Diamond, 2012) , F is the Faraday constant, D Ca is the diffusion coefficient of free calcium (220 mm 2 /s, Allbritton et al., 1992) , r is the distance between the vesicle and the calcium influx, and l is the characteristic length constant:
where K on is the rate of calcium binding to free buffer (Klingauf and Neher, 1997) and ½B free is the concentration of free buffer:
where ½B total is the total concentration of endogenous buffer, K D is the buffer dissociation constant and ½Ca 2 + basal is the basal free calcium concentration. Taken together, these three equations allowed us to calculate the initial calcium concentration as a function of distance from the point of calcium influx (assuming rapid equilibration at short distances). The calcium concentration then decayed exponentially, independent of distance, with a time constant of 40 ms to mimic slower timescale extrusion mechanisms (Brenowitz and Regehr, 2007) .
The second feature we added to this model was two Hill functions with realistic parameters for calcium affinity and cooperativity to mediate vesicle release and facilitation. The Hill parameters for both functions were adapted from electrophysiological as well as biochemical measurements of affinity and cooperativity for synaptotagmin1 and synaptotagmin7 (Brandt et al., 2012; Scimemi and Diamond, 2012; Sugita et al., 2002) . The initial release probability p release was calculated by the first, lower affinity Hill function using instantaneous initial calcium concentration immediately following the AP, which was then facilitated based on the residual calcium concentration preceding the AP via the second Hill function: (Equation 8B) and S, N, and EC 50 are parameters for maximum value, cooperativity, and half-maximal effective concentration, respectively. The values for cooperativity and half-maximal effective concentration were obtained from the literature (see Table S1 ), and the maximum value parameter S for the release and facilitation Hill functions was tuned to reproduce a realistic baseline release probability (based on OQA data, Figure 2 ) and modest baseline paired-pulse facilitation, respectively. In the initial reduced model, the increase in PPR with reductions in i CaV was the result of both release events being calculated with a single Hill function. With the addition of a second, higher affinity Hill function to mediate facilitation, it was necessary to incorporate vesicle depletion and replenishment parameters to account for the increases in paired-pulse facilitation observed with reductions in i CaV Scimemi and Diamond, 2012; Tsodyks and Markram, 1997) . Each ''synapse'' was paired with one vesicle (because synapses are independent in this model, one could equivalently conceptualize them as independent pairs of release sites and CaV clusters). At the beginning of each trial, it was assumed that all vesicles were replenished and available for release by defining a binary variable pool size. After calculating calcium influx and stochastic release for the first AP, the variable pool size was set to zero at synapses where release was successful. On the second AP, all synapses where pool size = 0 were randomly ''replenished'' (i.e., pool size set to 1) with a time-dependent probability:
where t is the time elapsed since the previous AP (i.e., the inter-stimulus interval), and t recov is the replenishment time constant. After determining if each empty release site was replenished, the release probability for the second AP was calculated as p corrected = pool size , p release (Equation 9B) where p release is the output of Equation 8A. In the reduced model of Figure 7 , when increasing the number of CaVs per synapse we reduced the single channel current in order to maintain constant the expected calcium concentration per synapse. Because we used realistic values for CaV single-channel current in the diffusion model, when increasing the number of channels per synapse we instead kept single-channel current constant and simply increased the CaV-vesicle distance to keep the expected value of the calcium concentration constant at each synapse (Figures S7F and S7I) . Without this adjustment, release probability would quickly saturate due to the Hill Function nonlinearity with the addition of even one CaV (data not shown, but see Figure S7G ). The following values for CaV-vesicle distance were used for synapses with the corresponding number of CaVs:
In some simulations, facilitation was modeled phenomenologically ( Figure S6 ). In these simulations, we began with the reduced model from Figure 7 , but rather than modeling exponential decay of calcium concentration, the vesicle release probability was calculated directly from the calcium influx per AP. The release probability for the second AP was then scaled according to the following formula:
where p initial is the initial release probability calculated from the Hill function of the calcium concentration, k is the facilitation parameter (''phenom_param,'' Table S1) Short-Term Dynamics in Voltage-and Current-clamp Evaluation of short-term plasticity for longer trains of stimuli and across different frequencies was achieved using the same preparation as earlier ChR2 stimulation experiments but with custom stimulation patterns (Figure 8 ). In order to quantify the relative suppression of ongoing activity relative to single EPSCs, we quantified the charge ratio: For current-clamp experiments (Figure 8 ), EPSP amplitude was monitored by stimulating once 250 ms before the onset of injected noisy current waveforms. In each cell, rheobase was estimated by injecting one-second long square pulses of current in 25 pA increments until at least one AP was evoked. The noise stimulus was generated by simulating EPSCs at 1,000 Hz as the product of two exponentials, with amplitude +25 pA and rise/decay time constants of 0.303/2.0 ms (Sohal et al., 2009 ). IPSCs were similarly generated, but with amplitude À25 pA at 250 Hz. The noisy current stimulus was then added to a square pulse of amplitude (rheobase -50 pA), as the mean of the noisy current stimulus was $50 pA. Following an initial LED pulse 500 ms after the onset of the noisy-current waveform, intervals corresponding to 1, 5, 10, and 20 Hz were shuffled, generating a train of LED stimuli of varying frequency. Pairs of trials with the same noisy current waveform were interleaved with and without LED stimulation (data not shown). After collecting baseline data, D1R and GABA B R agonists were bath-applied for 10 min before collecting the ''post-drug'' data.
Number CaVs
CaV-Vesicle Distance (nanometers) Offline, spikes were detected reliably by crossing 0 mV and LED-triggered averages of instantaneous frequency were calculated using 3 ms bins. The change in evoked spiking quantified in Figure 8J measured average instantaneous frequency in the 12 ms following an LED pulse. The same inclusion criteria were used for these experiments as outlined for ChR2 oEPSC experiments.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are shown as mean ± SEM, where ''n'' refers to the number of cells (for electrophysiological recording experiments) or boutons or spines (for Ca imaging experiments). Summary data and the name and results of statistical tests are interspersed with text in parentheticals in the Results section. Preliminary analysis and data visualization was performed in Igor Pro and MATLAB (MathWorks). Statistical tests used Kruskal-Wallis with Wilcoxon's rank-sum test and the Holm-Sidak correction for multiple comparisons. Significance was set to p < 0.05 unless otherwise stated.
DATA AND SOFTWARE AVAILABILITY
All code for computational models of vesicle release, and tutorials for simple simulations or replication, is available at https://github. com/kenburke/synapseModel.
